These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 29379364)

  • 1. DNA (cytosine-5)-methyltransferase 3B (
    Moura CM; Bastos PR; Ribeiro JSV; Ribeiro MG; Amorim MR; Costa-Lima MA
    Saudi J Biol Sci; 2018 Jan; 25(1):101-104. PubMed ID: 29379364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNMT3B promoter polymorphisms and maternal risk of birth of a child with Down syndrome.
    Coppedè F; Bosco P; Tannorella P; Romano C; Antonucci I; Stuppia L; Romano C; Migliore L
    Hum Reprod; 2013 Feb; 28(2):545-50. PubMed ID: 23081874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Betaine-homocysteine methyltransferase 742G>A polymorphism and risk of down syndrome offspring in a Brazilian population.
    Amorim MR; Moura CM; Gomes AD; Barboza HN; Lopes RB; Ribeiro MG; Costa Lima MA
    Mol Biol Rep; 2013 Aug; 40(8):4685-9. PubMed ID: 23645037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maternal risk for down syndrome and polymorphisms in the promoter region of the DNMT3B gene: a case-control study.
    Jaiswal SK; Sukla KK; Kumari N; Lakhotia AR; Kumar A; Rai AK
    Birth Defects Res A Clin Mol Teratol; 2015 Apr; 103(4):299-305. PubMed ID: 25656965
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Majstorović D; Barišić A; Božović IB; Čače IB; Čače N; Štifanić M; Vraneković J
    Genes (Basel); 2023 Feb; 14(3):. PubMed ID: 36980848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promoter polymorphisms of DNA methyltransferase 3B and risk of hepatocellular carcinoma.
    Lao Y; Wu H; Zhao C; Wu Q; Qiao F; Fan H
    Biomed Rep; 2013 Sep; 1(5):771-775. PubMed ID: 24649027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Folate gene polymorphism and the risk of Down syndrome pregnancies in young Chinese women].
    Liao YP; Bao MS; Liu CQ; Liu H; Zhang D
    Yi Chuan; 2010 May; 32(5):461-6. PubMed ID: 20466634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of DNA Methyltransferase 3B Promotor Polymorphism With Childhood Chronic Immune Thrombocytopenia.
    Gouda HM; Kamel NM; Meshaal SS
    Lab Med; 2016 Nov; 47(4):312-317. PubMed ID: 27590349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dihydrofolate Reductase (DHFR) del19bp Polymorphism and Down Syndrome Offspring.
    Costa-Lima MA; Barboza HN; Aprigio J; de Melo Moura C; Quirico-Santos TF; Ribeiro MG; Amorim MR
    J Mol Neurosci; 2020 Sep; 70(9):1410-1414. PubMed ID: 32445071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylenetetrahydrofolate reductase polymorphism is not risk factor for Down syndrome in North India.
    Rai V; Yadav U; Kumar P; Yadav SK
    Indian J Hum Genet; 2014 Apr; 20(2):142-7. PubMed ID: 25400341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphism of DNA methyltransferase 3B -149C/T and cancer risk: a meta-analysis.
    Zhu J; Du S; Zhang J; Wang Y; Wu Q; Ni J
    Med Oncol; 2015 Jan; 32(1):399. PubMed ID: 25433949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNMT3B rs1569686 and rs2424913 gene polymorphisms are associated with positive family history of preterm birth and smoking status.
    Barišić A; Kolak M; Peterlin A; Tul N; Gašparović Krpina M; Ostojić S; Peterlin B; Pereza N
    Croat Med J; 2020 Feb; 61(1):8-17. PubMed ID: 32118373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single nucleotide polymorphism in DNMT3B promoter and its association with hepatocellular carcinoma in a Moroccan population.
    Ezzikouri S; El Feydi AE; Benazzouz M; Afifi R; El Kihal L; Hassar M; Akil A; Pineau P; Benjelloun S
    Infect Genet Evol; 2009 Sep; 9(5):877-81. PubMed ID: 19465161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant promotor methylation in MDS hematopoietic cells during in vitro lineage specific differentiation is differently associated with DNMT isoforms.
    Hopfer O; Komor M; Koehler IS; Freitag C; Schulze M; Hoelzer D; Thiel E; Hofmann WK
    Leuk Res; 2009 Mar; 33(3):434-42. PubMed ID: 18829110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel C/T polymorphism in the core promoter of human de novo cytosine DNA methyltransferase 3B6 is associated with prognosis in head and neck cancer.
    Wang L; Rodriguez M; Kim ES; Xu Y; Bekele N; El-Naggar AK; Hong WK; Mao L; Oh YW
    Int J Oncol; 2004 Oct; 25(4):993-9. PubMed ID: 15375549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MTRR 66A>G polymorphism as maternal risk factor for Down syndrome: a meta-analysis.
    Amorim MR; Lima MA
    Genet Test Mol Biomarkers; 2013 Jan; 17(1):69-73. PubMed ID: 23094987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two-stage case-control study of DNMT-1 and DNMT-3B gene variants and breast cancer risk.
    Ye C; Beeghly-Fadiel A; Lu W; Long J; Shu XO; Gao YT; Zheng W; Cai Q
    Breast Cancer Res Treat; 2010 Jun; 121(3):765-9. PubMed ID: 19798569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Choline metabolic pathway gene polymorphisms and risk for Down syndrome: An association study in a population with folate-homocysteine metabolic impairment.
    Jaiswal SK; Sukla KK; Chauhan A; Lakhotia AR; Kumar A; Rai AK
    Eur J Clin Nutr; 2017 Jan; 71(1):45-50. PubMed ID: 27677362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Study of DNA Methyltransferase-3B Promoter Variant Genotype among Iranian Sporadic Breast Cancer Patients.
    Eftekhar E; Rasti M; Nahgibalhossaini F; Sadeghi Y
    Iran J Med Sci; 2014 May; 39(3):268-74. PubMed ID: 24850984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BHMT G742A and MTHFD1 G1958A polymorphisms and Down syndrome risk in the Brazilian population.
    Zampieri BL; Biselli JM; Goloni-Bertollo EM; Pavarino EC
    Genet Test Mol Biomarkers; 2012 Jun; 16(6):628-31. PubMed ID: 22339736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.